Jenkins John Kenneth
- SEC CIK
- 0001742557
In the past year, 1 open-market sale filing worth $38.0K and no purchases.
Current role at each company
- CRBP Corbus Pharmaceuticals Holdings, Inc.Directoras of Jun 11, 2026
- PRVB Provention Bio, Inc.Directoras of Apr 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $38.0K
- 1 filing
- Net
- −$38.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jenkins John Kenneth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRBP Corbus Pharmaceuticals Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Jenkins John KennethDirector | SSaleCommon Stock, par value $0.0001 per share | −4.80K | $7.91 | −$38.0K | −55.6%3.83K after | 10b5-1 |
| Jun 2, 2025 (view filing) | May 30 | 3 days | Jenkins John KennethDirector | SSaleCommon Stock, par value $0.0001 per share | −2.78K | $7.35 | −$20.5K | −98.8%33 after | 10b5-1 |